| |
|
|
| Name: |
Omega Fund Management (US) Inc. |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02116 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
13 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
KMTS |
Kestra Medical Technologies... |
1 |
New |
$17.67 |
$44,754,000 |
1,795,893 |
26.41% |
44,754,000 |
1,795,893 |
3.497 |
N/A |
|
|
BCAX |
Bicara Therapeutics Inc. |
2 |
- |
$8.71 |
$28,727,000 |
2,204,650 |
16.95% |
-9,678,000 |
0 |
4.053 |
N/A |
|
|
BBNX |
Beta Bionics, Inc. |
3 |
New |
$15.07 |
$24,337,000 |
1,988,287 |
14.36% |
24,337,000 |
1,988,287 |
4.587 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
4 |
- |
$10.42 |
$23,007,000 |
13,072,340 |
13.58% |
-11,765,000 |
0 |
6.034 |
N/A |
|
|
REPL |
Replimune Group Inc |
5 |
- |
$9.33 |
$19,258,000 |
1,975,203 |
11.36% |
-4,662,000 |
0 |
2.731 |
N/A |
|
|
UPB |
Upstream Bio, Inc. |
6 |
New |
$10.93 |
$12,462,000 |
2,036,293 |
7.35% |
12,462,000 |
2,036,293 |
3.842 |
N/A |
|
|
LXEO |
Lexeo Therapeutics, Inc. |
7 |
- |
$0.00 |
$4,111,000 |
1,184,636 |
2.43% |
-3,684,000 |
0 |
0 |
N/A |
|
|
ALMS |
Alumis Inc. |
8 |
- |
$3.02 |
$4,011,000 |
653,223 |
2.37% |
-1,123,000 |
0 |
1.383 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
9 |
- |
$0.00 |
$2,879,000 |
2,249,123 |
1.7% |
-810,000 |
0 |
4.66 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
10 |
- |
$3.66 |
$2,358,000 |
526,357 |
1.39% |
-1,142,000 |
0 |
1.192 |
N/A |
|
|
IMUX |
Immunic Inc |
11 |
- |
$0.70 |
$1,949,000 |
1,788,160 |
1.15% |
161,000 |
0 |
1.985 |
N/A |
|
|
SANA |
Sana Biotechnology, Inc. |
12 |
- |
$0.00 |
$1,418,000 |
843,750 |
0.84% |
43,000 |
0 |
0.45 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
13 |
Closed |
$0.03 |
$0 |
0 |
0% |
-58,000 |
-251,270 |
0 |
N/A |
|
